from Agensys and McGuff Pharmaceuticals
Wednesday, November 30, 2016
4:30 – 8:30 pm
Damon Jones, VP and Director of Operations, McGuff Pharmaceuticals, Inc.
Gary Welch, Vice President of Technical Operations, Agensys, Inc.
4:30 – 5:30 pm Registration and Networking with Los Angeles cGMP pharma manufacturing community, bring colleagues with you
5:30 – 6:30 pm Dinner
6:30 – 8:30 pm Presentations and Q& A
University Club of Pasadena
175 N. Oakland Ave., Pasadena, CA 91101 (626) 793-5157
About the Speakers
Damon Jones, VP and Director of Operations
McGuff Pharmaceuticals, Inc.
Topic of Talk:
Challenges and the Future of Compounding Pharmacy
The McGuff, Inc. Experience and Vision
This session will include McGuff Pharmaceuticals history, the evolution of McGuff Compounding Pharmacy Services Inc. (CPS), and McGuff Pharmaceuticals, Inc. (MPI), and plans to continue with 503A operation (Compounding Pharmacy under patient Rx). The launch of a new facility to expand commercial and 503B (“Outsourcing Facility”) capabilities to support clinical and commercial scale aseptically filled injectable drugs will also be discussed.
Damon Jones is the Vice President and Director of Operations at McGuff Pharmaceuticals, Inc. As an Operations and Manufacturing professional, he has more than 30 years of technical and managerial experience in the Medical Device and Pharmaceutical industries. Damon has direct experience in functions including managing all operational functions of device and pharmaceutical manufacturing, Microbiology and Chemistry, R&D, and corporate wide Operations and Quality Management systems.
He holds a BS Degree in Microbiology (Chemistry minor) and a Masters Degree in Business Administration. Additional certifications include Certified Quality Engineer (CQE) from the American Society for Quality.
Damon’s skills have been utilized by various companies including OrthoDiagnostics (a Johnson and Johnson Co.), Xenotech Laboratories, Inc., Medtronic, Inc., McGuff Pharmaceuticals, Inc. and others. Serving as Vice President to DEG Consulting in Southern California, Damon has helped varied clients achieve ISO and FDA compliance. In addition to his role at McGuff Pharmaceuticals, Inc., he continues to serve as Vice President to DEG Consulting and Quality Systems Advisor to McGuff CPS, Inc.
Gary Welch, Vice President of Technical Operations at Agensys, Inc.
Gary has over 24 years experience in biotechnology manufacturing. He has led organizations responsible for Engineering, Process and Analytical Development and Manufacturing. His experience includes the development and production of monoclonal antibodies, ADC’s, dual specific antibodies, enzymes and other recombinant proteins from both mammalian and microbial expression systems.
Gary leads the CMC functions at Agensys, which includes cell line, upstream, downstream, and ADC process development, formulation and analytical development, manufacturing of drug substance and drug product for pre-clinical and clinical use. In addition, he oversees engineering, facilities management, EH&S, and supply chain management.
Agensys, Inc., an affiliate of Astellas Pharma Inc., specializes in oncology biotherapeutic discovery and development.
He was previously the Director of Operations/Plant Manager at AbbVie in Worcester, MA. He was also the Director of Process Sciences, Director of Production and Process Engineering Manager for Abbott.
He has a BS in Chemical Engineering from Northeastern University, a MS in Chemical Engineering from Worcester Polytechnic Institute and a MBA in Finance from NYU.
$75 ISPE Members
$50 Young Professionals
$500 Event Sponsor (includes table top, your logo on promotions, recognition at the event and 2 admissions)